Dentists in Mc Kee, KY Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Jack T Fifield, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Us Hwy 421 S Main Street, Mc Kee, KY 40447 Phone: 606-287-8326 Fax: 606-287-8327 |
 Dr. Elly Jo Jones, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1010 Main St S, Mc Kee, KY 40447 Phone: 606-287-7104 Fax: 606-287-4409 |
Dr. Bruce E. Stewart, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1010 Main St S, Mc Kee, KY 40447 Phone: 606-287-7104 Fax: 606-287-3323 |
Dr. Andrea Henderson, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1010 Main St S, Mc Kee, KY 40447 Phone: 606-287-7104 Fax: 606-287-4409 |
News Archive
Boston Scientific receives regulatory approval to market RELIANCE 4-FRONT in Europe and Asia
Boston Scientific Corporation has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
New 3-D mapping and labeling system reduces scan time and improves work flow
Researchers have developed an automated 3-D mapping and labeling system that reduces scan time and improves the work flow, efficiency, and accuracy of routine freehand ultrasound exams, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
In the fight for money for the opioid crisis, will the youngest victims be left out?
Babies born to mothers who used opioids during pregnancy represent one of the most distressing legacies of an opioid epidemic that has claimed almost 400,000 lives and ravaged communities.
ISCO discovers novel technology to produce pure hepatocyte population
International Stem Cell Corporation announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells.
Patterson Companies fourth quarter consolidated sales increase 9% to $883,819,000
Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.
› Verified 1 days ago